FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Geisbert

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Vero Cells

Procedures

Physiology

Virus Replication

Co-author Network

Publications

TOP 3
David Safronetz; Dana P Scott; Nafomon Sogoba; James E Strong; Douglas Brining; Friederike Feldmann; Thomas W Geisbert; Elaine Haddock; Heinz Feldmann
A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.
David Safronetz; Thomas W Geisbert; Heinz Feldmann
Animal models for highly pathogenic emerging viruses.
Andrea Marzi; Dana P Scott; W Lesley Shupert; Douglas Brining; Flora Engelmann; Friederike Feldmann; Heinz Feldmann; Thomas W Geisbert; Kristen Haberthur; Michael G Katze; Yoshihiro Kawaoka; Ilhem Messaoudi
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Geisbert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David Safronetz; Dana P Scott; Nafomon Sogoba; James E Strong; Douglas Brining; Friederike Feldmann; Thomas W Geisbert; Elaine Haddock; Heinz Feldmann
A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.
The Journal of infectious diseases 2013;207(8):1316-27.
2013: David Safronetz; Thomas W Geisbert; Heinz Feldmann
Animal models for highly pathogenic emerging viruses.
Current opinion in virology 2013;3(2):205-9.
2013: Andrea Marzi; Dana P Scott; W Lesley Shupert; Douglas Brining; Flora Engelmann; Friederike Feldmann; Heinz Feldmann; Thomas W Geisbert; Kristen Haberthur; Michael G Katze; Yoshihiro Kawaoka; Ilhem Messaoudi
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(5):1893-8.
2012: Katharine N Bossart; Douglas Brining; Christopher C Broder; Yee Peng Chan; Friederike Feldmann; Heinz Feldmann; Yan-Ru Feng; Joan B Geisbert; Andrew C Hickey; Rachel LaCasse; Barry Rockx; Dana Scott; Thomas W Geisbert
A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
Science translational medicine 2012;4(146):146ra107.
2011: Darryl Falzarano; Friederike Feldmann; Hideki Ebihara; Joan B Geisbert; Thomas W Geisbert; Jason Gren; Allen Grolla; Shane Jones; Steven M Jones; Anders Leung; Andrea Marzi; James E Strong; Ayato Takada; Heinz Feldmann
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.
The Journal of infectious diseases 2011;204 Suppl 3():S1082-9.
2011: Andrea Marzi; Kinola J Williams; Julie Callison; Hideki Ebihara; Thomas W Geisbert; Allison Groseth; Heinz Feldmann
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.
The Journal of infectious diseases 2011;204 Suppl 3():S1066-74.
2011: Judy Y Yen; Anna N Honko; Kate Rubins; Yu Xia; John H Connor; Sara Garamszegi; Joan B Geisbert; Thomas W Geisbert; Lisa E Hensley
Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
The Journal of infectious diseases 2011;204 Suppl 3():S1043-52.
2011: Katharine N Bossart; Douglas Brining; Christopher C Broder; Julie Callison; Yee Peng Chan; Antony S Dimitrov; Dimiter S Dimitrov; Friederike Feldmann; Heinz Feldmann; Yan-Ru Feng; Joan B Geisbert; Thomas W Geisbert; Andrew C Hickey; Dana Scott; Yanping Wang; Lianying Yan; Zhongyu Zhu; Barry Rockx
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.
Science translational medicine 2011;3(105):105ra103.
2011: Nancy J Sullivan; Gene Garrard Olinger; SRINIVAS RAO; Keith A Reimann; Mario Roederer; Daphne Stanley; Clement Asiedu; Michael Bailey; Saran Bao; Joan B Geisbert; Thomas W Geisbert; Lisa E Hensley; Anna N Honko; Peter B Jahrling; Joshua Johnson; Richard A Koup; Gary Nabel
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.
Nature medicine 2011;17(9):1128-31.
2011: Thomas W Geisbert; Michael Bailey; Lisa E Hensley; Clement Asiedu; Joan B Geisbert; Daphne Stanley; Anna Honko; Joshua Johnson; Sabue Mulangu; Maria G Pau; Jerome H H V Custers; Jort Vellinga; Jenny Hendriks; Peter B Jahrling; Mario Roederer; Jaap Goudsmit; Richard A Koup; Nancy J Sullivan
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
Journal of virology 2011;85(9):4222-33.
2011: Carlos A Lopez; George G Daaboul; Rahul S Vedula; Emre Ozkumur; David A Bergstein; Thomas W Geisbert; Helen E Fawcett; Bennett B Goldberg; John H Connor; M Selim Unlü
Label-free multiplexed virus detection using spectral reflectance imaging.
Biosensors & bioelectronics 2011;26(8):3432-7.
2011: Heinz Feldmann; Thomas W Geisbert
Ebola haemorrhagic fever.
Lancet 2011;377(9768):849-62.
2011: Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Pathogenesis of Lassa fever in cynomolgus macaques.
Virology journal 2011;8():205.
2010: Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.
Archives of virology 2010;155(12):2083-103.
2010: Barry Rockx; Katharine N Bossart; Friederike Feldmann; Joan B Geisbert; Andrew C Hickey; Douglas Brining; Julie Callison; David Safronetz; Andrea Marzi; Lisa Kercher; Dan Long; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
Journal of virology 2010;84(19):9831-9.
2010: Thomas W Geisbert; Michael Bailey; Joan B Geisbert; Clement Asiedu; Mario Roederer; Maria Grazia-Pau; Jerome H H V Custers; Peter B Jahrling; Jaap Goudsmit; Richard A Koup; Nancy J Sullivan
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
Journal of virology 2010;84(19):10386-94.
2010: Darci R Smith; Sarah McCarthy; Andrew Chrovian; Gene Garrard Olinger; Andrea Stossel; Thomas W Geisbert; Lisa E Hensley; John H Connor
Inhibition of heat-shock protein 90 reduces Ebola virus replication.
Antiviral research 2010;87(2):187-94.
2010: Thomas W Geisbert; Lisa E Hensley; Joan B Geisbert; Anders Leung; Joshua C Johnson; Allen Grolla; Heinz Feldmann
Postexposure treatment of Marburg virus infection.
Emerging infectious diseases 2010;16(7):1119-22.
2010: Thomas W Geisbert; Amy C H Lee; Marjorie Robbins; Joan B Geisbert; Anna N Honko; Vandana Sood; Joshua C Johnson; Susan de Jong; Iran Tavakoli; Adam Judge; Lisa E Hensley; Ian Maclachlan
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.
Lancet 2010;375(9729):1896-905.
2010: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Andrew C Hickey; Mark A Smith; Yee Peng Chan; Lin-Fa Wang; Joseph J Mattapallil; Joan B Geisbert; Katharine N Bossart; Christopher C Broder
Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.
PloS one 2010;5(5):e10690.
2009: James LeDuc; Kevin Anderson; Marshall E Bloom; Ricardo Carrion; Heinz Feldmann; J Patrick Fitch; Joan B Geisbert; Thomas W Geisbert; Michael R Holbrook; Peter B Jahrling; Thomas G Ksiazek
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.
Emerging infectious diseases 2009;15(7):e1.
2009: Thomas W Geisbert; Joan B Geisbert; Anders Leung; Kathleen M Daddario-DiCaprio; Lisa E Hensley; Allen Grolla; Heinz Feldmann
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Journal of virology 2009;83(14):7296-304.
2008: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Douglas S Reed; Friederike Feldmann; Allen Grolla; Ute Ströher; Elizabeth A Fritz; Lisa E Hensley; Steven M Jones; Heinz Feldmann
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
Vaccine 2008;26(52):6894-900.
2008: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Mark G Lewis; Joan B Geisbert; Allen Grolla; Anders Leung; Jason Paragas; Lennox Matthias; Mark A Smith; Steven M Jones; Lisa E Hensley; Heinz Feldmann; Peter B Jahrling
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
PLoS pathogens 2008;4(11):e1000225.
2008: James W Le Duc; Kevin Anderson; Marshall E Bloom; James E Estep; Heinz Feldmann; Joan B Geisbert; Thomas W Geisbert; Lisa Hensley; Michael Holbrook; Peter B Jahrling; Thomas G Ksiazek; George W Korch; Jean L Patterson; John P Skvorak; Hana Weingartl
Framework for leadership and training of Biosafety Level 4 laboratory workers.
Emerging infectious diseases 2008;14(11):1685-8.
2008: Elizabeth A Fritz; Joan B Geisbert; Thomas W Geisbert; Lisa E Hensley; Douglas S Reed
Cellular immune response to Marburg virus infection in cynomolgus macaques.
Viral immunology 2008;21(3):355-63.
2008: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Kinola J N Williams; Joan B Geisbert; Anders Leung; Friederike Feldmann; Lisa E Hensley; Heinz Feldmann; Steven M Jones
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
Journal of virology 2008;82(11):5664-8.
2007: Peter B Jahrling; Joan B Geisbert; James R Swearengen; Thomas Larsen; Thomas W Geisbert
Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
The Journal of infectious diseases 2007;196 Suppl 2():S400-3.
2007: Lisa E Hensley; Edward L Stevens; S Betty Yan; Joan B Geisbert; William L Macias; Tom Larsen; Kathleen M Daddario-DiCaprio; Gail H Cassell; Peter B Jahrling; Thomas W Geisbert
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.
The Journal of infectious diseases 2007;196 Suppl 2():S390-9.
2007: Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Howard A Young; Pierre Formenty; Elizabeth A Fritz; Tom Larsen; Lisa E Hensley
Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.
The Journal of infectious diseases 2007;196 Suppl 2():S372-81.
2007: Ayato Takada; Hideki Ebihara; Heinz Feldmann; Thomas W Geisbert; Yoshihiro Kawaoka
Epitopes required for antibody-dependent enhancement of Ebola virus infection.
The Journal of infectious diseases 2007;196 Suppl 2():S347-56.
2007: Thomas Larsen; Edward L Stevens; Kelly J Davis; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Peter B Jahrling; Lisa E Hensley; Thomas W Geisbert
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.
The Journal of infectious diseases 2007;196 Suppl 2():S323-8.
2007: Hideki Ebihara; Steven Theriault; Gabriele Neumann; Judie B Alimonti; Joan B Geisbert; Lisa E Hensley; Allison Groseth; Steven M Jones; Thomas W Geisbert; Yoshihiro Kawaoka; Heinz Feldmann
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
The Journal of infectious diseases 2007;196 Suppl 2():S313-22.
2007: Steven B Bradfute; Denise R Braun; Joshua D Shamblin; Joan B Geisbert; Jason Paragas; Aura Garrison; Lisa E Hensley; Thomas W Geisbert
Lymphocyte death in a mouse model of Ebola virus infection.
The Journal of infectious diseases 2007;196 Suppl 2():S296-304.
2007: Heinz Feldmann; Thomas W Geisbert; Yoshihiro Kawaoka
Filoviruses: recent advances and future challenges.
The Journal of infectious diseases 2007;196 Suppl 2():S129-30.
2007: Gabriele Neumann; Thomas W Geisbert; Hideki Ebihara; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Heinz Feldmann; Yoshihiro Kawaoka
Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates.
Journal of virology 2007;81(6):2995-8.
2007: Kate Rubins; Lisa E Hensley; Victoria Wahl-Jensen; Kathleen M Daddario-DiCaprio; Howard A Young; Douglas S Reed; Peter B Jahrling; Patrick O Brown; David A Relman; Thomas W Geisbert
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.
Genome biology 2007;8(8):R174.
2007: Gustavo Palacios; Phenix-Lan Quan; Omar Jabado; Sean Conlan; David L Hirschberg; Yang Liu; Junhui Zhai; Neil Renwick; Jeffrey Hui; Hedi Hegyi; Allen Grolla; James E Strong; Jonathan S Towner; Thomas W Geisbert; Peter B Jahrling; Cornelia Büchen-Osmond; Heinz Ellerbrok; Maria Paz Sanchez-Seco; Yves lussier; Pierre Formenty; M Stuart T Nichol; Heinz Feldmann; Thomas Briese; W Ian Lipkin
Panmicrobial oligonucleotide array for diagnosis of infectious diseases.
Emerging infectious diseases 2007;13(1):73-81.
2007: Wendelien B Oswald; Thomas W Geisbert; Kelly J Davis; Joan B Geisbert; Nancy J Sullivan; Peter B Jahrling; Paul W H I Parren; Dennis R Burton
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.
PLoS pathogens 2007;3(1):e9.
2007: Heinz Feldmann; Steven M Jones; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Ute Ströher; Allen Grolla; Mike Bray; Elizabeth A Fritz; Lisa Fernando; Friederike Feldmann; Lisa E Hensley; Thomas W Geisbert
Effective post-exposure treatment of Ebola infection.
PLoS pathogens 2007;3(1):e2.
2006: Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Joan B Geisbert; Ute Ströher; Lisa E Hensley; Allen Grolla; Elizabeth A Fritz; Friederike Feldmann; Heinz Feldmann; Steven M Jones
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
Journal of virology 2006;80(19):9659-66.
2006: Thomas W Geisbert; Lisa E Hensley; Elliott Kagan; Erik Zhaoying Yu; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Elizabeth A Fritz; Peter B Jahrling; Kevin McClintock; Janet R Phelps; Amy C H Lee; Adam Judge; Lloyd B Jeffs; Ian MacLachlan
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
The Journal of infectious diseases 2006;193(12):1650-7.
2006: Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Devon Shedlock; Ling Xu; Laurie Lamoreaux; Jerome H H V Custers; Paul M Popernack; Zhi-Yong Yang; Maria G Pau; Mario Roederer; Richard A Koup; Jaap Goudsmit; Peter B Jahrling; Gary Nabel
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.
PLoS medicine 2006;3(6):e177.
2006: Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Ute Ströher; Joan B Geisbert; Allen Grolla; Elizabeth A Fritz; Lisa Fernando; Elliott Kagan; Peter B Jahrling; Lisa E Hensley; Steven M Jones; Heinz Feldmann
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Lancet 2006;367(9520):1399-404.
2006: Gustavo Palacios; Thomas Briese; Vishal Kapoor; Omar Jabado; Zhiqiang Liu; Marietjie Venter; Junhui Zhai; Neil Renwick; Allen Grolla; Thomas W Geisbert; Christian Drosten; Jonathan S Towner; Jingyue Ju; Janusz T Paweska; Stuart T Nichol; Robert Swanepoel; Heinz Feldmann; Peter B Jahrling; W Ian Lipkin
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever.
Emerging infectious diseases 2006;12(4):692-5.
2006: Jason Paragas; Thomas W Geisbert
Development of treatment strategies to combat Ebola and Marburg viruses.
Expert review of anti-infective therapy 2006;4(1):67-76.
2005: Lisa E Hensley; Steven M Jones; Heinz Feldmann; Peter B Jahrling; Thomas W Geisbert
Ebola and Marburg viruses: pathogenesis and development of countermeasures.
Current molecular medicine 2005;5(8):761-72.
2005: Heinz Feldmann; Steven M Jones; Hans-Joachim Schnittler; Thomas W Geisbert
Therapy and prophylaxis of Ebola virus infections.
Current opinion in investigational drugs (London, England : 2000) 2005;6(8):823-30.
2005: Lisa E Hensley; Thomas W Geisbert
The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates.
Thrombosis and haemostasis 2005;94(2):254-61.
2005: Steven M Jones; Heinz Feldmann; Ute Ströher; Joan B Geisbert; Lisa Fernando; Allen Grolla; Hans-Dieter Klenk; Nancy J Sullivan; Viktor Volchkov; Elizabeth A Fritz; Kathleen M Daddario; Lisa E Hensley; Peter B Jahrling; Thomas W Geisbert
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Nature medicine 2005;11(7):786-90.
2005: Thomas W Geisbert; Steven Jones; Elizabeth A Fritz; Amy C Shurtleff; Joan B Geisbert; Ryan Liebscher; Allen Grolla; Ute Ströher; Lisa Fernando; Kathleen M Daddario; Mary C Guttieri; Bianca R Mothé; Tom Larsen; Lisa E Hensley; Peter B Jahrling; Heinz Feldmann
Development of a new vaccine for the prevention of Lassa fever.
PLoS medicine 2005;2(6):e183.
2004: Thomas W Geisbert; Peter B Jahrling
Exotic emerging viral diseases: progress and challenges.
Nature medicine 2004;10(12 Suppl):S110-21.
2004: Kate Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James LeDuc; Patrick O Brown; David A Relman
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(42):15190-5.
2004: Thomas W Geisbert; Lisa E Hensley
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
Expert reviews in molecular medicine 2004;6(20):1-24.
2004: Lisa E Hensley; Lisa E Fritz; Peter B Jahrling; Christopher L Karp; John W Huggins; Thomas W Geisbert
Interferon-beta 1a and SARS coronavirus replication.
Emerging infectious diseases 2004;10(2):317-9.
2004: Douglas S Reed; Lisa E Hensley; Joan B Geisbert; Peter B Jahrling; Thomas W Geisbert
Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.
Viral immunology 2004;17(3):390-400.
2004: Randal J Schoepp; Michelle D Morin; Mark J Martinez; David A Kulesh; Lisa E Hensley; Thomas W Geisbert; Daniel R Brady; Peter B Jahrling
Detection and identification of Variola virus in fixed human tissue after prolonged archival storage.
Laboratory investigation; a journal of technical methods and pathology 2004;84(1):41-8.
2003: Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
Lancet 2003;362(9400):1953-8.
2003: Thomas W Geisbert; Peter B Jahrling
Towards a vaccine against Ebola virus.
Expert review of vaccines 2003;2(6):777-89.
2003: Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Elliott Kagan; Lisa E Hensley
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
The Journal of infectious diseases 2003;188(11):1618-29.
2003: Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Tom Larsen; Elliott Kagan; Lisa E Hensley
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
The American journal of pathology 2003;163(6):2371-82.
2003: Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
The American journal of pathology 2003;163(6):2347-70.
2003: Boyd Yount; Kris Curtis; Elizabeth A Fritz; Lisa E Hensley; Peter B Jahrling; Erik Prentice; Mark Denison; Thomas W Geisbert; Ralph S Baric
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12995-3000.
2003: Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Ling Xu; Zhi-Yong Yang; Mario Roederer; Richard A Koup; Peter B Jahrling; Gary Nabel
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Nature 2003;424(6949):681-4.
2003: Alemka Markotic; L Hensley; Thomas W Geisbert; Kristin Spik; Connie S Schmaljohn
Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells.
The Journal of general virology 2003;84(Pt 8):2197-202.
2002: Felix Meissner; Toshiaki Maruyama; Marco Frentsch; Ann J Hessell; Luis L Rodriguez; Thomas W Geisbert; Peter B Jahrling; Dennis R Burton; Paul W H I Parren
Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.
Virology 2002;300(2):236-43.
2002: Paul W H I Parren; Thomas W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.
Journal of virology 2002;76(12):6408-12.
2002: Thomas W Geisbert; Peter Pushko; Kevin Anderson; Jonathan Smith; Kelly J Davis; Peter B Jahrling
Evaluation in nonhuman primates of vaccines against Ebola virus.
Emerging infectious diseases 2002;8(5):503-7.
2002: Sina Bavari; Catharine M Bosio; Elizabeth Wiegand; Gordon Ruthel; Amy B Will; Thomas W Geisbert; Michael Hevey; Connie S Schmaljohn; Alan L Schmaljohn; M Javad Aman
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.
The Journal of experimental medicine 2002;195(5):593-602.
2002: Lisa E Hensley; Howard A Young; Peter B Jahrling; Thomas W Geisbert
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.
Immunology letters 2002;80(3):169-79.
2002: Thomas W Geisbert; Lisa E Hensley; Joan B Geisbert; Peter B Jahrling
Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
Virology 2002;293(1):15-9.
2001: G M Zaucha; Peter B Jahrling; Thomas W Geisbert; James R Swearengen; Lisa E Hensley
The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).
Laboratory investigation; a journal of technical methods and pathology 2001;81(12):1581-600.
2001: T R Gibb; Mike Bray; Thomas W Geisbert; KE Steele; WM Kell; Kelly J Davis; NK Jaax
Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
Journal of comparative pathology 2001;125(4):233-42.
2000: Thomas W Geisbert; Lisa E Hensley; T R Gibb; KE Steele; NK Jaax; Peter B Jahrling
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.
Laboratory investigation; a journal of technical methods and pathology 2000;80(2):171-86.
1999: Mike Bray; K Davis; Thomas W Geisbert; Connie S Schmaljohn; John W Huggins
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
The Journal of infectious diseases 1999;179 Suppl 1():S248-58.
1999: Peter B Jahrling; Thomas W Geisbert; Joan B Geisbert; James R Swearengen; Mike Bray; NK Jaax; John W Huggins; James LeDuc; Clarence Peters
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.
The Journal of infectious diseases 1999;179 Suppl 1():S224-34.
1999: B M Connolly; KE Steele; Kelly J Davis; Thomas W Geisbert; WM Kell; NK Jaax; Peter B Jahrling
Pathogenesis of experimental Ebola virus infection in guinea pigs.
The Journal of infectious diseases 1999;179 Suppl 1():S203-17.
1998: Mike Bray; K Davis; Thomas W Geisbert; Connie S Schmaljohn; John W Huggins
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
The Journal of infectious diseases 1998;178(3):651-61.
1998: Thomas W Geisbert; NK Jaax
Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy.
Ultrastructural pathology 1998;22(1):3-17.
1997: Peter Vogel; David Fritz; K Kuehl; Kelly J Davis; Thomas W Geisbert
The agents of biological warfare.
JAMA : the journal of the American Medical Association 1997;278(5):438-9.
1997: Kelly J Davis; Arthur O. Anderson; Thomas W Geisbert; KE Steele; Joan B Geisbert; Peter Vogel; B M Connolly; John W Huggins; Peter B Jahrling; NK Jaax
Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.
Archives of pathology & laboratory medicine 1997;121(8):805-19.
1996: William Hall; Thomas W Geisbert; John W Huggins; Peter B Jahrling
Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease.
The American journal of tropical medicine and hygiene 1996;55(1):81-8.
1996: James Norman Mills; Julio G Barrera Oro; DS Bressler; J E Childs; Robert B Tesh; J F Smith; Delia Enria; Thomas W Geisbert; K T McKee; Michael D Bowen; Clarence Peters; Peter B Jahrling
Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus).
The American journal of tropical medicine and hygiene 1996;54(4):399-404.
1996: Peter B Jahrling; Thomas W Geisbert; NK Jaax; M A Hanes; Thomas G Ksiazek; Clarence Peters
Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic.
Archives of virology. Supplementum 1996;11():115-34.
1996: E D Johnson; B K Johnson; D Silverstein; Peter M Tukei; Thomas W Geisbert; Anthony Sanchez; Peter B Jahrling
Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya.
Archives of virology. Supplementum 1996;11():101-14.
1995: NK Jaax; Peter B Jahrling; Thomas W Geisbert; Joan B Geisbert; KE Steele; K McKee; D Nagley; E Johnson; G Jaax; C Peters
Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.
Lancet 1995;346(8991-8992):1669-71.
1995: Thomas W Geisbert; Peter B Jahrling
Differentiation of filoviruses by electron microscopy.
Virus research 1995;39(2-3):129-50.
1994: R H Kenyon; B Niklasson; Peter B Jahrling; Thomas W Geisbert; L Svensson; Aril Frydén; M Bengtsson; U Foberg; C J Peters
Virologic investigation of a case of suspected haemorrhagic fever.
Research in virology 1994;145(6):397-406.
1993: Thomas W Geisbert; Peter B Jahrling; J W Ezzell
Use of immunoelectron microscopy to demonstrate Francisella tularensis.
Journal of clinical microbiology 1993;31(7):1936-9.
1992: Thomas W Geisbert; Peter B Jahrling; M A Hanes; P M Zack
Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States.
Journal of comparative pathology 1992;106(2):137-52.
1991: Thomas W Geisbert; J B Rhoderick; Peter B Jahrling
Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy.
Journal of clinical pathology 1991;44(6):521-2.
1990: Thomas W Geisbert; Peter B Jahrling
Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic.
Journal of clinical pathology 1990;43(10):813-6.
1990: Peter B Jahrling; Thomas W Geisbert; D W Dalgard; E D Johnson; Thomas G Ksiazek; William Hall; C J Peters
Preliminary report: isolation of Ebola virus from monkeys imported to USA.
Lancet 1990;335(8688):502-5.